How Hospice Organizations Can Reduce DME Costs Without Cutting Quality

Reimbursement Is Tightening. DME Is Controllable.

The 2026 Medicare hospice payment update of 2.6% - while welcome, doesn't fully offset the cost pressures hospices face from inflation, staffing costs, and growing clinical complexity. In this environment, every controllable cost line deserves scrutiny.

DME is among the most controllable, and most underoptimized, cost categories in hospice. Unlike labor costs, which are constrained by the availability of skilled workers and the clinical requirements of patient care, DME spend can be meaningfully reduced through better systems, better vendor management, and better data. Not by ordering less equipment, or ordering lower-quality equipment, but by eliminating the waste that exists in nearly every hospice DME program operating without dedicated management infrastructure.

This guide is for hospice CEOs, CFOs, and COOs who want to understand where their DME dollars are going, and what to do about it.

How Much Are You Actually Spending on DME?

Before you can manage DME cost, you need to see it. This sounds obvious. In practice, most hospices don't have a clean number.

DME spending is often distributed across multiple vendor invoices, tracked inconsistently across locations, and summarized only in monthly financial reports that show a total without category or patient-level detail. Leadership knows roughly how much the hospice spends on DME per month. They typically don't know:

• Which equipment categories drive the most cost
• Which vendors are charging above-market rates
• Which patients have equipment that isn't clinically indicated at their current level of care
• How their DME cost per patient per day compares to peer organizations
• How much of their DME spend is off-formulary

Without this information, cost management is guesswork. With it, targeted action becomes possible.

The first step in any DME cost-reduction effort is data consolidation: getting all vendor invoices into a single view, categorized by item type, patient, location, and vendor. This alone often reveals surprises.

The Five Biggest Drivers of Avoidable DME Spend

Based on experience across hundreds of hospice organizations, these five patterns account for the majority of avoidable DME spending:

1. Formulary drift. Clinical staff order above the formulary, selecting premium items when standard items are clinically appropriate, without explicit approval. Over time, this drift becomes the de facto standard, and cost per patient per day creeps upward. Formulary drift is almost never intentional; it's the result of clinical staff making individual decisions without visibility into cost implications.

2. Vendor concentration. Hospices that rely on one or two vendors for the majority of their DME have limited negotiating use and no competitive pricing pressure. Vendors who know they have a captive customer don't have incentive to sharpen their pricing.

3. Duplicate orders. Without centralized order tracking, the same item can be ordered twice, once by the admitting nurse and once by the case manager, or once for a patient who was recently discharged and once for a newly admitted patient with the same address. Duplicate orders are a surprisingly common and entirely preventable source of waste.

4. Late returns. Equipment that isn't picked up promptly after a patient dies or is discharged continues to appear on vendor invoices. Some hospices are paying rental costs for equipment that has been sitting in an empty house for weeks. A disciplined return coordination process, part of what a DME Benefits Manager like Qualis provides, eliminates this.

5. Off-formulary creep. Related to formulary drift but distinct: off-formulary items that are approved for one patient with a specific clinical need become standard practice for other patients without similar needs. The approval for one patient doesn't automatically extend to all patients, but in an informal ordering environment, that distinction can blur.

Formulary Management as a Cost Control Strategy

A managed formulary is the single most effective cost control tool available to a hospice DME program. Here is why:

It creates a cost baseline. When every item ordered is on the formulary, and the formulary has defined items with defined pricing through contracted vendors, the expected cost per patient per day becomes predictable. Variances from that baseline are visible and explainable.

It requires clinical justification for above-baseline spending. When a Tier 2 or Tier 3 item requires review and approval, the approval process forces a cost-conscious consideration. Clinical staff are not asked to deny clinically necessary care, they're asked to document why a more expensive option is warranted.

It creates accountability without removing clinical judgment. A well-designed formulary doesn't prevent clinical staff from ordering what patients need. It creates a structured process for above-formulary orders that makes clinical reasoning visible and auditable.

Vendor Competition and Network Strategy

The vendor side of DME cost management is often overlooked. Many hospices have vendor relationships built on familiarity and inertia rather than competitive analysis.

Why a multi-vendor network lowers average cost. When a hospice orders all its DME through a single vendor, that vendor has limited pricing incentive. When a hospice maintains an active multi-vendor network, vendors compete for business, and pricing responds accordingly.

The service-cost balance. Vendor selection cannot be based on price alone. A vendor whose prices are 15% below market but whose delivery reliability is poor costs more than a slightly more expensive vendor with excellent service levels, because equipment delivery failures generate clinical escalations, staff labor, and family dissatisfaction that have real costs.

->  How a DME Benefits Manager manages this. Qualis maintains vendor relationships with 900+ suppliers across the country, with contracted pricing and service level agreements. Rather than managing individual vendor relationships, and the administrative burden that entails, hospices access the entire network through a single platform, with order routing that optimizes for price, availability, and delivery reliability simultaneously.

The ROI of a DME Benefits Manager

For hospices evaluating the financial case for a dedicated DME management platform, the ROI calculation has several components:

Direct cost savings. Formulary optimization, vendor pricing improvements, and elimination of wasteful spending (duplicates, late returns, off-formulary drift) typically generate $50,000–$200,000 in annual savings for mid-sized hospices, depending on census volume.

Administrative labor recaptured. The hours that clinical and administrative staff spend on vendor phone calls, invoice reconciliation, order follow-up, and return coordination are hours not spent on patient care. Automating these workflows doesn't just save money, it redirects clinical capacity toward the patient.

CAHPS performance. Higher CAHPS scores from better equipment reliability translate to marketing value, referral relationships, and, in value-based care contexts, direct financial outcomes.

Compliance risk reduction. Audit-ready documentation of every order, delivery, and return reduces compliance exposure and the cost of responding to audits.

Frequently Asked Questions

Is it possible to reduce DME costs without switching vendors?

Yes. Formulary management, return coordination improvement, and eliminating duplicate orders can all be achieved within an existing vendor structure. That said, vendor pricing is often the largest single lever, and accessing competitive pricing typically requires a multi-vendor approach.

What's the fastest way to get visibility into our current DME spend?

Invoice consolidation is the fastest starting point. Get all vendor invoices for the past three months into a single spreadsheet, categorized by item type and patient. This alone will reveal the top cost drivers. Qualis offers a free DME evaluation that does this analysis and benchmarks your spending against comparable organizations.

How does a DME Benefits Manager generate ROI?

Through a combination of direct cost savings (better pricing, formulary discipline, eliminated waste) and administrative efficiency gains (automated ordering, tracking, and reconciliation). The ROI is typically measurable within the first full quarter of operation.

->  Qualis is the nation's first DME Benefits Manager for post-acute care providers. Our platform provides the visibility, vendor network, and operational infrastructure that hospices need to manage DME costs without compromising care quality.